Kolexia
Pobel Cédric Oncologie médicale
Pobel Cédric
Oncologie médicale
Gustave-Roussy
Villejuif, France
54 Activités
31 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs de la prostate Tumeurs prostatiques résistantes à la castration Leucopénie Carcinomes Carcinome transitionnel Neutropénie Métastase tumorale Tumeurs de la vessie urinaire Cholangiocarcinome

Collaborateurs

Voir plus
Massard Christophe
Massard Christophe
Gustave-Roussy, Villejuif, France
Helissey Carole
Helissey Carole
Hopital Instruction des Armees Begin, Saint-Mandé, France
Besse Benjamin
Besse Benjamin
Gustave-Roussy, Villejuif, France
Cancel Mathilde
Cancel Mathilde
Centre hospitalier de Tours, Tours, France

Industries

Voir plus
Janssen
1 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Genomic Profiling of Metastatic Castration-Resistant Prostate Cancer Samples Resistant to Androgen Receptor Pathway Inhibitors.
Clinical cancer research : an official journal of the American Association for Cancer Research   02 novembre 2023
Development of Novel Models of Aggressive Variants of Castration-resistant Prostate Cancer.
European urology oncology   26 octobre 2023
Clinical utility of plasma ctDNA sequencing in metastatic urothelial cancer.
European journal of cancer (Oxford, England : 1990)   06 octobre 2023
Resistance to Selective FGFR Inhibitors in FGFR-Driven Urothelial Cancer.
Cancer discovery   07 septembre 2023
MATCH-R: A Prospective Trial to Study the Evolution of Clonal Architecture of Tumors From Patients Treated With Molecular Targeted Agents
Essai Clinique (Gustave-Roussy)   17 août 2023
Abstract 3458: Resistance to selective FGFR inhibitors in FGFR-driven urothelial cancer
Proceedings: AACR Annual Meeting 2023   01 avril 2023
1405P Circulating tumor DNA in advanced prostate cancer: Focus on high blood tumor mutational burden (h-bTMB)
Abstract Book of the ESMO Congress 2022, 9 - 13 September 2022   01 septembre 2022
Prognostic value of tumor immune biomarkers in biopsies from patients with refractory solid cancers.
Cancer treatment and research communications   19 juillet 2022
CABASTY: Randomized Multicenter, Phase III Trial Evaluating the Safety of 2 Schedules of Cabazitaxel (Bi-weekly Versus Tri-weekly) Plus Prednisone in Elderly Men (≥ 65years) With mCRPC Previously Treated With a Docetaxel-containing Regimen
Essai Clinique (Association Pour La Recherche des Thérapeutiques Innovantes en Cancérologie)   09 mai 2022
Impact of Novel Hormonal Agents (Abiraterone, Enzalutamide) on the Development of Visceral and/or Brain Metastases in Patients With Bone-metastatic Castration-resistant Prostate Cancer.
Clinical genitourinary cancer   21 avril 2022